Skip to content

Accelerated long-term forgetting in multiple sclerosis 2

Accelerated long-term forgetting in multiple sclerosis 2 - ALF-MS 2

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00035204
Enrollment
120
Registered
2025-04-17
Start date
2025-05-20
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G35

Interventions

Group 1: Patients with multiple sclerosis the following tests are completed/the following questionnaires are completed: BDI FEAG FEDA MoCA WMSI-IV RAVLT ESS EMQS FIS-D PSQI SDMT In addition, specifi

Sponsors

Carl von Ossietzky Universität Oldenburg - Abteilung für Neurologie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Diagnosis of multiple sclerosis according to the revised McDonald criteria (Thompson et al., 2018), all subgroups (relapsing-remitting multiple sclerosis (RRMS), secondary progressive multiple sclerosis (SPMS) and primary progressive multiple sclerosis (PPMS)) and all degrees of severity are permitted. Patients must be capable of providing information and be able to reflect sufficiently on the decision to participate in the study; this criterion is checked before the information is provided. The prerequisite for participation in the study is German as a native language.

Exclusion criteria

Exclusion criteria: Exclusion criteria for MS patients: Signs of depression (BDI > 20) Taking medication that modifies memory performance (e.g. anticholinergics for the treatment of bladder weakness) Diseases other than multiple sclerosis that can impair brain function Exclusion criteria for the control subjects: Presence of a psychiatric or neurological illness Regular use of medication that interacts with the function of the CNS

Design outcomes

Primary

MeasureTime frame
H1: Patients with multiple sclerosis show reduced memory performance in retaining verbal information (1. RAVLT recall after 7 days / RAVLT recall after 30 min, 2. WMSI recall after 7 days / WMSI recall after 30 min) (indicated as: QRAVLT or QWMS) after 7 days compared to age-, gender- and education-matched healthy subjects.

Secondary

MeasureTime frame
N1: Disturbances in the recall of verbal information over a longer period of time are an expression of a subjectively experienced memory impairment and correlate with the questionnaires collected, with a negative correlation of QRAVLT and QWMS to FEAG and EMQ and a positive correlation to FEDA. N2: Disturbances in the retrieval of verbal information over a longer period of time are due to impaired sleep-bound memory consolidation and therefore correlate with the sleep score. N3: Disturbances in the recall of verbal information after a longer period of time correlate with the severity of fatigue and therefore also with the FIS-D score.

Countries

Germany

Contacts

Public ContactKarsten Witt

Carl von Ossietzky Universität Oldenburg - Abteilung für Neurologie

karsten.witt@uni-oldenburg.de+49 (0)441 798-4657

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 26, 2026